Mufg Securities Americas Inc. Has $2.59 Million Stock Position in McKesson Corporation $MCK

Mufg Securities Americas Inc. increased its holdings in shares of McKesson Corporation (NYSE:MCK) by 21.0% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 3,355 shares of the company’s stock after acquiring an additional 582 shares during the quarter. Mufg Securities Americas Inc.’s holdings in McKesson were worth $2,592,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. IAM Advisory LLC lifted its holdings in shares of McKesson by 0.3% during the 3rd quarter. IAM Advisory LLC now owns 3,908 shares of the company’s stock valued at $3,019,000 after purchasing an additional 13 shares in the last quarter. PDS Planning Inc lifted its stake in McKesson by 1.1% in the third quarter. PDS Planning Inc now owns 1,209 shares of the company’s stock valued at $934,000 after buying an additional 13 shares in the last quarter. Berkshire Asset Management LLC PA boosted its holdings in shares of McKesson by 4.6% in the third quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company’s stock valued at $227,000 after buying an additional 13 shares during the period. Goldstein Advisors LLC increased its position in shares of McKesson by 4.4% during the third quarter. Goldstein Advisors LLC now owns 334 shares of the company’s stock worth $258,000 after acquiring an additional 14 shares in the last quarter. Finally, Warren Street Wealth Advisors LLC raised its holdings in shares of McKesson by 4.9% during the third quarter. Warren Street Wealth Advisors LLC now owns 319 shares of the company’s stock worth $246,000 after acquiring an additional 15 shares during the period. 85.07% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Maria Martinez sold 349 shares of McKesson stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the transaction, the director owned 301 shares in the company, valued at approximately $282,900.87. This trade represents a 53.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 1,143 shares of company stock worth $1,046,070. Company insiders own 0.08% of the company’s stock.

Analysts Set New Price Targets

MCK has been the subject of a number of research reports. Robert W. Baird set a $968.00 target price on McKesson in a report on Wednesday, January 14th. UBS Group lifted their target price on McKesson from $920.00 to $980.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Barclays upped their price target on McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 18th. Morgan Stanley reiterated an “overweight” rating and issued a $966.00 price objective on shares of McKesson in a report on Thursday, January 29th. Finally, Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Thirteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $943.50.

McKesson Stock Up 0.0%

Shares of McKesson stock opened at $947.58 on Tuesday. The stock has a market cap of $116.07 billion, a P/E ratio of 27.25, a P/E/G ratio of 1.53 and a beta of 0.40. McKesson Corporation has a 12-month low of $598.58 and a 12-month high of $971.93. The business’s 50 day moving average is $856.14 and its 200-day moving average is $798.99.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same period in the previous year, the company earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, sell-side analysts expect that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.3%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.